Reports and Data

Oncology Nutrition Market in-Depth Analysis by Top Players: Hormel Foods, Fresenius Kabi AG, Meiji Holdings : Market Size by 2026 - USD 2.77 Billion : Market Growth - CAG

This Oncology Nutrition Market report covers the status of import and export, supply chain management, distribution channels, production volume, production capacity, product price, profit, sale and others elements.

 

New York, NY -- (SBWIRE) -- 05/09/2019 -- Increasing demand for home care nutritional products and increasing demand to meet cancer patient's nutritional requirements are the major factors driving oncology nutritional market growth.

This report on Oncology Nutrition Market offers a detailed analysis of the trends along with the prospective growth of the same in the forecasted period. It evaluates the pricing, demand, growth, revenue, size and gross margin of the industry. For this study, the historical data has been collected from the years 2016 and 2017, taking the year 2018 as the base year and drawing a forecast for the years 2019 to 2026. The industry has seen a stable growth recently and its demand is projected to rise rapidly in the future.
The Oncology Nutrition Market is forecast to grow from USD 1.52 Billion in 2018 to USD 2.77 Billion by 2026, at a CAGR of 8.2%, during the forecast period. The market is primarily driven by the increasing demand for home care nutritional products and increasing demand to meet cancer patient's nutritional requirements.

The major players in the market are Hormel Foods (US), Fresenius Kabi AG (Germany), Meiji Holdings (Japan), Nestle S.A. (Switzerland), Mead Johnson Nutrition Company (US), Abbott Laboratories (US), Danone (France), B. Braun Melsungen AG (Germany), Victus (US), Global Health Products (US) and others

Request free sample to understand the structure of the complete report: https://www.reportsanddata.com/sample-enquiry-form/1374

Dietary factors are identified as having a significant impact on cancer risk, with different dietary elements increasing as well as reducing risk. Diet and obesity can be associated with up to 30% to 35% of deaths from cancer, whereas physical inactivity appears to be associated with 7% cancer risk.

About 85% of all cases of cancer are caused by diet and lifestyle. Food is vital. It can contribute to cancer development as well as help the cancer process prevention and management. Clinical outcomes are significantly improved by using Oncology Nutrition as an integrated and holistic approach to cancer.

Overall market growth is driven largely by shifting focus from parenteral to enteral nutrition, increasing cancer incidence, increasing demand for nutritional requirements in the home care sector, increasing number of patients being treated for malnutrition, and increasing the quality of nutritional interventions in clinical research.

Further key findings from the report suggest
- The Oncology Nutrition Market is forecasted to grow from USD 1.52 Billion in 2018 to USD 2.77 Billion by 2026, at a CAGR of 8.2%, during the forecast period. The market is primarily driven by the increasing demand for home care nutritional products and increasing demand to meet cancer patient's nutritional requirements.
- Based on cancer type, the market is segmented into breast, liver, stomach & gastrointestinal, head & neck, pancreatic, esophageal, lung, blood and other cancers. The head & neck segment is expected to hold the largest market share throughout the forecast period. It is expected to reach USD 560.5 Million in 2026, at a CAGR of 9.7% during the forecast period.
- Based on distribution channel, the market is segmented into hospitals, online pharmacies and retail pharmacies. The hospital is expected to hold the largest market share during the forecast period. It is expected to reach USD 1.06 Billion in 2026, at a CAGR of 8.5% during the forecast period.
- Based on nutrition support, the market is segmented into enteral nutrition and parenteral nutrition. The enteral nutrition market is expected to hold the largest market share throughout the forecast period. It is expected to grow at a CAGR of 8.3% during the forecast period.
- Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America. The North America region is expected to hold the largest market share throughout the forecast period. It is expected to reach USD 1.01 Billion in 2026, at a CAGR of 8.6% during the forecast period. North America is showing significant market growth due to the increasing prevalence of chronic diseases and disorders, coupled with the rapidly growing aging population, showing greater susceptibility to chronic and acute disorders than other segments of the population.

Order Now (Customized delivered as per your business requirement): https://www.reportsanddata.com/checkout-form/1374

Some of the key findings from our Oncology Nutrition Market forecast report
This report gives an analysis of the historical data and trends to draw a forecast of the potential growth Oncology Nutrition Market exhibits a potential for growth and technological advancement primarily in its uses in rubber industries and shall experience a stable growth in the next five years. The historical analysis suggest certain trends that the industry might experience and the prospects of growth during the forecasted years. This study also offers vital insights into the industry to provide the fields that are the most beneficial for investment and gives a competitive strategy that is most advantageous in the industry.

Segments covered in the report:
This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the market on the basis of type, stages, distribution channel, nutrition support end use and regional analysis.

Type (Revenue, USD Million; 2016-2026)
- Stomach and Gastrointestinal Cancers
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Esophageal Cancer
- Head and Neck Cancer
- Pancreatic Cancer
- Blood Cancer
- Other Cancers
- Distribution C

End User (Revenue, USD Million; 2016-2026)
- Hospitals
- Clinics

Distribution Channel (Revenue, USD Million; 2016-2026)Glass
- Hospitals
- Retail Pharmacies
- Online Pharmacies

Stages (Revenue, USD Million; 2016-2026)
- Chemotherapy
- Hormone therapy
- Radiation therapy
- Surgery
- Immunotherapy
- Stem cell transplant

Nutrition Support (Revenue, USD Million; 2016-2026)
- Enteral Nutrition
- Parenteral Nutrition

Regional Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)
- North America
o U.S.
- Europe
o France
o UK
- Asia Pacific
o China
o India
o Japan
- Latin America
o Brazil
- MEA

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/oncology-nutrition-market

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com